Liver and biliary tract cancer trials in Austria
15 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
- Where
- Krems, Linz, Vienna, Wels
- Age
- 18 years and over
- People
- 700 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07284121 - No phaseTaking peopleObservational Study Protocol: LIVER-R
- Where
- Linz, Sankt Pölten, Vienna
- Age
- 18 years to 130 years
- People
- 4,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06252753 - Phase 3Taking peoplePhase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Where
- Graz, Linz, Salzburg, Vienna, Wiener Neustadt
- Age
- 18 years to 99 years
- People
- 620 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00 - No phaseTaking peopleSARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors
- Where
- Graz, Linz, Sankt Pölten, Sankt Veit an der Glan, Wels
- People
- 200
- Run by
- Medical University of Graz
See details and how to joinNCT07341321 - Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Graz, Vienna
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 3Taking peopleA Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR) altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma (FIRST-308)
- Where
- Linz, Wiener Neustadt
- Age
- 18 years and over
- People
- 126 worldwide
- Run by
- Transthera Sciences (Nanjing) Inc.
See details and how to join2023-505660-11-00 · EU 2023-505660-11-00 - No phaseTaking peopleDRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- Where
- Vienna
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- Maastricht University Medical Center
See details and how to joinNCT07717437 - No phaseNot yet taking people in AustriaDigitally Supported Prehabilitation Before Major Visceral Cancer Surgery
- Where
- Saint Veit Im Pongau, Salzburg
- Age
- 18 years and over
- People
- 30
- Run by
- Ludwig Boltzmann Institute for Digital Health and Prevention
See details and how to joinNCT07658313 - Phase 2Taking people– IKF/AIO-QUINTIS – A Randomized Phase II Trial Evaluating Fruquintinib in Combination with Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer without Active Liver Metastases
- Where
- Linz, Salzburg, Wiener Neustadt
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
See details and how to join2024-519929-38-00 · EU 2024-519929-38-00 - No phaseNot yet taking people in Austria3D Liver Volumetry
- Where
- Graz
- Age
- 18 years and over
- People
- 25
- Run by
- Medical University of Graz
See details and how to joinNCT07297615 - Phase 4Taking peopleHOPE Against Cancer Recurrence in HCC
- Where
- Innsbruck, Vienna
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Philipp Dutkowski
See details and how to joinNCT06717919 - No phaseTaking peopleThe Dragon PLC Trial (DRAGON-PLC)
- Where
- Vienna
- Age
- 18 years and over
- People
- 358 worldwide
- Run by
- Maastricht University
See details and how to joinNCT06914648 - Phase 3Taking peopleThe ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
- Where
- Graz, Innsbruck, Klagenfurt Am Woerthersee, St. Pölten, Vienna
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
See details and how to joinNCT04803994 · EU 2024-512953-26-00 - No phaseTaking peopleThe DRAGON 2 Trial
- Where
- Vienna
- Age
- 18 years and over
- People
- 348 worldwide
- Run by
- Maastricht University
See details and how to joinNCT05428735 - No phaseTaking peopleVienna Hypothermic Oxygenated Machine Perfusion Study
- Where
- Vienna
- Age
- 18 years and over
- People
- 500
- Run by
- Medical University of Vienna
See details and how to joinNCT06418165